Page last updated: 2024-08-23

substance p and Pulmonary Hypertension

substance p has been researched along with Pulmonary Hypertension in 15 studies

Research

Studies (15)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	10 (66.67)	18.2507
2000's	4 (26.67)	29.6817
2010's	1 (6.67)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chen, KH; Chen, MJ; Lai, YL	1
Chen, MJ; Lai, YL	1
Fischer, A; Springer, J	1
Archer, SL; Hampl, V; Nelson, DP; Weir, EK	1
Lai, YL; Zhou, KR	1
Chen, CF; Chien, CT; Lai, YL; Shiao, HL; Thacker, AA; Zhang, HQ	1
Brett, SJ; Evans, TW; Gibbs, R; Pepper, JR; Simon, J	1
Diana, JN; Lai, YL; Thacker, AA	1
Cailes, J; du Bois, RM; Evans, TW; Winter, S	1
Chen, CF; Lai, YL; Wu, HD	1
Chen, CF; Chen, LW; Lai, YL	1
Bush, A; Collins, P; Kelleher, A; Li, J; Morgan, C; Penny, DJ; Redington, AN; Rigby, ML; Schulze-Neick, I; Shinebourne, EA	1
Chen, MJ; Chiang, LY; Lai, YL	1
Katzman, NJ; Lai, YL	1
Crake, T; Ludman, PF; Oakley, CM; Uren, NG	1

Trials

2 trial(s) available for substance p and Pulmonary Hypertension

Article	Year
Impairment of endothelium-dependent pulmonary vasodilation in patients with primary pulmonary hypertension. Thorax, 1996, Volume: 51, Issue:1 Topics: Adenosine; Cardiac Output; Dose-Response Relationship, Drug; Endothelium, Vascular; Humans; Hypertension, Pulmonary; Pulmonary Veins; Substance P; Vascular Resistance; Vasodilation	1996
Defective endothelially mediated pulmonary vasodilation in systemic sclerosis. Chest, 1998, Volume: 114, Issue:1 Topics: Adenosine; Adult; Capillaries; Cardiac Output; Echocardiography, Doppler; Endothelium, Vascular; Female; Humans; Hypertension, Pulmonary; Infusions, Intravenous; Lung; Male; Microcirculation; Middle Aged; Prospective Studies; Pulmonary Circulation; Scleroderma, Systemic; Stroke Volume; Substance P; Vascular Resistance; Vasodilation; Vasodilator Agents	1998

Article

Year

Impairment of endothelium-dependent pulmonary vasodilation in patients with primary pulmonary hypertension.

Thorax, 1996, Volume: 51, Issue:1

Topics: Adenosine; Cardiac Output; Dose-Response Relationship, Drug; Endothelium, Vascular; Humans; Hypertension, Pulmonary; Pulmonary Veins; Substance P; Vascular Resistance; Vasodilation

1996

Defective endothelially mediated pulmonary vasodilation in systemic sclerosis.

Chest, 1998, Volume: 114, Issue:1

Topics: Adenosine; Adult; Capillaries; Cardiac Output; Echocardiography, Doppler; Endothelium, Vascular; Female; Humans; Hypertension, Pulmonary; Infusions, Intravenous; Lung; Male; Microcirculation; Middle Aged; Prospective Studies; Pulmonary Circulation; Scleroderma, Systemic; Stroke Volume; Substance P; Vascular Resistance; Vasodilation; Vasodilator Agents

1998

Other Studies

13 other study(ies) available for substance p and Pulmonary Hypertension

Article	Year
Oxygen radicals and substance P in perinatal hypoxia-exaggerated, monocrotaline-induced pulmonary hypertension. The Chinese journal of physiology, 2012, Apr-30, Volume: 55, Issue:2 Topics: Animals; Antioxidants; Atmosphere Exposure Chambers; Blood Pressure; Body Weight; Capsaicin; Female; Heart Rate; Humans; Hypertension, Pulmonary; Hypoxia; Male; Monocrotaline; Pregnancy; Prenatal Exposure Delayed Effects; Rats; Rats, Wistar; Reactive Oxygen Species; Sensory System Agents; Substance P	2012
Tachykinin dysfunction attenuates monocrotaline-induced pulmonary hypertension. Toxicology and applied pharmacology, 2003, Mar-15, Volume: 187, Issue:3 Topics: Animals; Blood Pressure; Body Weight; Heart Rate; Hypertension, Pulmonary; Hypertrophy, Right Ventricular; Male; Monocrotaline; Organ Size; Rats; Rats, Wistar; Receptors, Tachykinin; RNA Interference; RNA, Double-Stranded; Substance P; Tachykinins	2003
Substance P-induced pulmonary vascular remodelling in precision cut lung slices. The European respiratory journal, 2003, Volume: 22, Issue:4 Topics: Animals; Cell Division; Culture Techniques; Hypertension, Pulmonary; Hypoxia; Hypoxia-Inducible Factor 1, alpha Subunit; Lung; Mice; Myocytes, Smooth Muscle; Reactive Oxygen Species; Substance P; Transcription Factors	2003
Chronic EDRF inhibition and hypoxia: effects on pulmonary circulation and systemic blood pressure. Journal of applied physiology (Bethesda, Md. : 1985), 1993, Volume: 75, Issue:4 Topics: Animals; Arginine; Blood Pressure; Cardiac Output; Hemodynamics; Hypertension, Pulmonary; Hypoxia; In Vitro Techniques; Lung; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Organ Size; Perfusion; Pulmonary Circulation; Rats; Rats, Sprague-Dawley; Substance P; Vasodilation	1993
Capsaicin pretreatment attenuates monocrotaline-induced ventilatory dysfunction and pulmonary hypertension. Journal of applied physiology (Bethesda, Md. : 1985), 1993, Volume: 75, Issue:6 Topics: Animals; Blood Pressure; Body Weight; Capsaicin; Cardiomegaly; Endopeptidases; Hypertension, Pulmonary; Monocrotaline; Nerve Fibers; Radioimmunoassay; Rats; Rats, Sprague-Dawley; Respiratory Function Tests; Respiratory Tract Diseases; Substance P	1993
Capsaicin pretreatment attenuates chronic hypoxic pulmonary hypertension. Respiration physiology, 1995, Volume: 99, Issue:2 Topics: Animals; Blood Pressure; Capsaicin; Chronic Disease; Female; Hypertension, Pulmonary; Hypoxia; Neprilysin; Pulmonary Circulation; Random Allocation; Rats; Rats, Wistar; Substance P; Tachykinins	1995
Hypoxemia and elevated tachykinins in rat monocrotaline pneumotoxicity. Lung, 1996, Volume: 174, Issue:3 Topics: Animals; Hypertension, Pulmonary; Hypoxia; Lung; Male; Monocrotaline; Neprilysin; Pulmonary Gas Exchange; Rats; Rats, Sprague-Dawley; Substance P; Time Factors	1996
Antioxidants attenuate chronic hypoxic pulmonary hypertension. Journal of cardiovascular pharmacology, 1998, Volume: 32, Issue:5 Topics: Animals; Antioxidants; Body Weight; Chronic Disease; Free Radicals; Hypertension, Pulmonary; Hypoxia; Male; Rats; Rats, Wistar; Substance P; Thiourea	1998
Chronic activation of neurokinin-1 receptor induces pulmonary hypertension in rats. The American journal of physiology, 1999, Volume: 276, Issue:5 Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Atmospheric Pressure; Biphenyl Compounds; Blood Pressure; Cardiac Output; Female; Hypertension, Pulmonary; Hypertrophy, Right Ventricular; Hypoxia; Neurokinin-1 Receptor Antagonists; Pulmonary Wedge Pressure; Rats; Rats, Wistar; Receptors, Neurokinin-1; Receptors, Neurokinin-3; Substance P; Vascular Resistance	1999
L-arginine and substance P reverse the pulmonary endothelial dysfunction caused by congenital heart surgery. Circulation, 1999, Aug-17, Volume: 100, Issue:7 Topics: Administration, Inhalation; Arginine; Cardiopulmonary Bypass; Endothelium, Vascular; Heart Defects, Congenital; Humans; Hypertension, Pulmonary; Infant; Infusions, Intravenous; Nitric Oxide; Oxygen; Postoperative Complications; Pulmonary Circulation; Substance P; Vascular Resistance; Vasodilation; Vasodilator Agents	1999
Reactive oxygen species and substance P in monocrotaline-induced pulmonary hypertension. Toxicology and applied pharmacology, 2001, Mar-15, Volume: 171, Issue:3 Topics: Animals; Body Weight; Carbon; Free Radical Scavengers; Hematocrit; Hypertension, Pulmonary; Immunoenzyme Techniques; Luminescent Measurements; Male; Monocrotaline; Muscle, Smooth, Vascular; Poisons; Pulmonary Artery; Pulmonary Circulation; Rats; Rats, Wistar; Reactive Oxygen Species; Substance P; Thiourea	2001
Capsaicin pre- and post-treatment on rat monocrotaline pneumotoxicity. The Chinese journal of physiology, 2000, Dec-31, Volume: 43, Issue:4 Topics: Animals; Capsaicin; Functional Residual Capacity; Hypertension, Pulmonary; Hypertrophy, Right Ventricular; Male; Monocrotaline; Neprilysin; Neurokinin A; Organ Size; Rats; Rats, Sprague-Dawley; Substance P; Total Lung Capacity	2000
Response of the pulmonary circulation to acetylcholine, calcitonin gene-related peptide, substance P and oral nicardipine in patients with primary pulmonary hypertension. Journal of the American College of Cardiology, 1992, Mar-15, Volume: 19, Issue:4 Topics: Acetylcholine; Adult; Calcitonin Gene-Related Peptide; Endothelium, Vascular; Female; Humans; Hypertension, Pulmonary; Male; Nicardipine; Pulmonary Artery; Pulmonary Circulation; Substance P; Vascular Resistance; Vasodilation	1992